|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/12 | (2006.01) |
| A61K2039/545 | (2013.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61K2039/55 | (2013.01) | ||
| C12N2760/18634 | (2013.01) | ||
| A61K 39/12 | (2013.01) | ||
| A61P 31/14 | (2018.01) | ||
| A61K 39/155 | (2013.01) | ||
| A61K2039/53 | (2013.01) | ||
| A61K2039/55505 | (2013.01) | ||
| A61K2039/55555 | (2013.01) | ||
| A61K2039/55566 | (2013.01) | ||
| A61K2039/575 | (2013.01) | ||
| C12N2760/18534 | (2013.01) | ||
| C12N2760/18571 | (2013.01) |
| (11) | Patento numeris | 3527224 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19165302.1 |
| Europos patento paraiškos padavimo data | 2012-01-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-02-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161436355 P | 2011-01-26 | US |
| (72) |
DORMITZER, Philip, R. , US
|
| (73) |
GlaxoSmithKline Biologicals S.A. ,
Rue de l'Institut, 89, 1330 Rixensart,
BE
|
| (54) | RSV IMMUNIZATION REGIMEN |
| RSV IMMUNIZATION REGIMEN |